Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate

Silke Glage; Andrew L. Lewis; Patricia Mertens; Steffen Baltes; Peter Geigle; Thomas Brinker

首页> 外文期刊>Clinical and Translational Oncology >Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate

【24h】

Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate

机译：评估藻酸盐中阿霉素和伊立替康药物洗脱微珠悬浮液的生物相容性和抗神经胶质瘤功效

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction Chemotherapeutic drug-eluting beads (DEBs) are microspheres that are in clinical use for intraarterial chemoembolisation of liver cancer. Here we report on the biocompatibility and anti-tumour efficacy of DEBs after intratumoral application in a rat BT4Ca glioma model.

机译：简介化疗药物洗脱珠（DEB）是微球，临床上用于肝癌的动脉内化学栓塞。在这里，我们报告在大鼠BT4Ca胶质瘤模型中进行肿瘤内应用后，DEBs的生物相容性和抗肿瘤功效。

著录项

来源
《Clinical and Translational Oncology 》 |2012年第1期| p.50-59| 共10页
作者
Silke Glage; Andrew L. Lewis; Patricia Mertens; Steffen Baltes; Peter Geigle; Thomas Brinker;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate. [J] . Silke Glage, Andrew L Lewis, Patricia Mertens, Clinical & translational oncology : . 2012 ,第1期

机译：评估藻酸盐中阿霉素和伊立替康药物洗脱微珠悬浮液的生物相容性和抗神经胶质瘤功效。
2. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases [J] . Bhutiani Neal, Akinwande Olaguoke, Martin Robert C. G. II World Journal of Surgery: Official Journal of the Societe Internationale de Chirurgie, Collegium Internationale Chirurgiae Digestivae, and of the International Association of Endocrine Surgeons . 2016 ,第5期

机译：肝动脉内药物洗脱（伊立替康）微珠（DEBIRI）疗法在伊立替康难治性不可切除结直肠肝转移中的疗效和毒性
3. Investigation of the mechanisms governing doxorubicin and irinotecan release from drug-eluting beads: mathematical modeling and experimental verification [J] . Marco Biondi, Sabato Fusco, Andrew L. Lewis, Journal of materials science . 2013 ,第10期

机译：控制阿霉素和伊立替康从药物洗脱珠释放的机制的研究：数学建模和实验验证
4. Study on kinetics and biocompatibility evaluation of multiple polymer layer with biochemical material properties in drug-eluting stent [C] . Sergey PAVLINICH, XiWei LIU, Hong ZHAO, International Conference on Intelligent Materials and Mechanical Engineering . 2013

机译：药物洗脱支架中多聚合物层的动力学和生物相容性评价研究
5. Feasibility safety and pharmacokinetic study of hepatic administration of drug-eluting beads loaded with irinotecan (DEBIRI) followed by intravenous administration of irinotecan in a porcine model [O] . Andrew L. Lewis, Rachel R. Holden, S. Ting Chung, -1

机译：在猪模型中肝给药装有伊立替康（DEBIRI）的药物洗脱珠然后静脉内给药伊立替康的可行性安全性和药代动力学研究
6. Feasibility, safety and pharmacokinetic study of hepatic administration of drug-eluting beads loaded with irinotecan (DEBIRI) followed by intravenous administration of irinotecan in a porcine model [O] . Lewis A., Holden R., Chung S., 2013

机译：肝脏给药伊立替康（DEBIRI）药物洗脱珠的可行性，安全性和药代动力学研究，然后在猪模型中静脉注射伊立替康

Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate

摘要

著录项

相似文献

相关主题

期刊订阅